WHAT’S NEW: > Intarcia to Present at JPMorgan    HealthCare Conference > Intarcia Announces Interim Results from Phase 2    Study of Omega Interferon in HCV > Intarcia Announces Its Phase 3 Clinical Trial    For Advanced Breast Cancer > Intarcia Closes $50M Private Financing > Intarcia launches new site for its Phase 3 trial    for breast cancer
	COMPANY | PEOPLE | PRODUCTS | CAREERS | CONTACT | HOME © Intarcia Therapeutics, Inc. | Privacy Policy